Sjogrens Syndrome Foundation   Report issue

Foundation Phase 1
Founded: Reston VA United States (1983)

Organization Overview

First Clinical Trial
2019
NCT03926286
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Sjogrens Syndrome Foundation

Active Ingredients

Drugs in Phase 1 Trials (1)

human fecal microbiota (Reybota) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sjogren's Syndrome (Phase 1)

Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1